Conference Coverage: ASCO GU 2023 Highlights

Expert perspectives and strategic insights on the latest therapeutic developments in GU cancer treatment from the 2023 ASCO GU Cancers Symposium, and implications on individualized clinical decision-making.

February 22, 2023
Daniel Petrylak, MD, Yale, Aptitude Health

FACULTY CHAIR

Daniel Petrylak, MD

Yale Cancer Center, New Haven, CT, USA

Faculty Members

TBC

Agenda

Download the meeting agenda

View Agenda

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

A report will be produced that is based on the meeting, and will discuss the following topics

  • Prostate Cancer Part 1 – Hormonal Therapies and Chemotherapies
  • Prostate Cancer Part 2 – Targeted Therapies
  • Bladder Cancer Part 1 – ADCs
  • Bladder Cancer Part 2 – PARP Inhibitors and Immunotherapies
  • Renal Cell Carcinoma

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.